ADVISORY RESEARCH INC Halozyme Therapeutics, Inc. Transaction History

ADVISORY RESEARCH INC portfolio value:

$1.49M
portfolio value

ADVISORY RESEARCH INC quarter portfolio value change:

-10.14%
quarter

Halozyme Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +6.64% 2.36K shares -66K $39.54 37.91K
Q2 2022 share Increase 0.00% 35.55K shares 1.56M $44 35.55K